The impact of AGEs on human health and the development of their inhibitors based on natural compounds

dc.contributor.authorSadeghi, Morteza
dc.contributor.authorMiroliaei, Mehran
dc.contributor.authorKamyabiamineh, Alireza
dc.contributor.authorTaslimi, Parham
dc.contributor.authorGhanadian, Mustafa
dc.contributor.authorTaslimi, Parham
dc.date.accessioned2025-10-18T10:02:20Z
dc.date.created2023
dc.date.issued2023
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstractAdvanced glycation end products (AGEs) are a heterogeneous group of complex chemical entities resulting from non-enzymatic reactions between reducing sugars with proteins, lipids and/or nucleic acids. AGEs tend to accumulate in cells and stimulate diverse signaling pathways that are closely related to the emergence of several chronic metabolic disorders. This review is based on keywords medicinal plant, AGEs, AGEs complication, AGEs inhibitor and their characteristics. The keywords are widely identified and checked in databases such as Science Direct, PubMed Medline, Scopus, and Google Scholar. The complex processes of AGEs formation and their impact on human health are reviewed along with recent developments in AGEs inhibitors derived from natural compounds. In addition, the mechanisms of action of natural inhibitors such as quercetin, lignan, chlorogenic acid, resveratrol and stilbenes are summarized in the protection of glycation-sensitive sites in proteins, removal of active carbonyl compounds, chelating metal ions, and reduction of blood glucose levels. Despite showing glycation-induced-free radicals scavenging activity, these compounds have not yet been widely used in clinical field. Therefore, such natural compounds with specific molecular frameworks might have great potential to pave the way of new drugs discovery. & COPY; 2023 Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dc.identifier.doi10.1016/j.arabjc.2023.105143
dc.identifier.issn1878-5352
dc.identifier.issn1878-5379
dc.identifier.issue10
dc.identifier.orcidTaslimi, Parham/0000-0002-3171-0633
dc.identifier.orcidSadeghi, Morteza/0000-0002-5027-4777;
dc.identifier.scopus2-s2.0-85165086380
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.arabjc.2023.105143
dc.identifier.urihttps://hdl.handle.net/11772/20553
dc.identifier.volume16
dc.identifier.wosWOS:001045855700001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofArabian Journal of Chemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzWoS_20251016
dc.subjectAges
dc.subjectDiabetes Complication
dc.subjectAntiglycation Compounds
dc.titleThe impact of AGEs on human health and the development of their inhibitors based on natural compounds
dc.typeReview Article
dspace.entity.typePublication
relation.isAuthorOfPublicationdadfa319-65b8-4543-92b4-bea49e0139e9
relation.isAuthorOfPublication.latestForDiscoverydadfa319-65b8-4543-92b4-bea49e0139e9

Dosyalar